| Net earnings | -56.5M |
| Depreciation and amortization | 212.6M |
| Deferred taxes | -1.4M |
| Stock-based compensation expense | 38.4M |
| Gain on sale of facilities | |
| Other | -1.3M |
| Trade receivables | 36.3M |
| Inventories | -7M |
| Accounts payable | -102.8M |
| Accrued liabilities | -10.4M |
| Other assets and liabilities | 1M |
| Net cash flows provided by operating activities | 128.1M |
| Purchases of property, plant and equipment | -57.1M |
| Purchases of marketable securities | 0 |
| Proceeds from sales of marketable securities | 0 |
| Proceeds from maturities of marketable securities | 0 |
| Purchases of companies net of cash acquired | 0 |
| Proceeds from sales of facilities | |
| Other | 4.9M |
| Net cash flows used for investing activities | -52.2M |
| Repayment of assumed long-term debt | 0 |
| Other | -3M |
| Net cash flows provided by (used for) financing activities | -118M |
| Effect of exchange rate changes on cash | 1.5M |
| Net change in cash and cash equivalents | -40.6M |
| Cash and cash equivalents - beginning of period | 158.3M |
| Cash and cash equivalents - end of period | 117.7M |